IR-Med appoints co-founder Aharon Klein as Interim CEO effective Feb. 28, 2024

IR-Med, Inc.

Aharon Klein, age 60, currently CTO and co-founder, becomes Interim CEO of IR-Med and its Israeli subsidiary.
Klein co-founded IR-Med in 2013, served as COO until 2020, then CTO; prior experience includes FertiliGent and a medical device startup.
Klein continues under same service provider agreement with no disclosed change in compensation terms.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Aharon Klein

Interim Chief Executive Officer

IR-Med, Inc.

Effective: 2024-02-28
Filed: March 5, 2024, 6:59 PM ET

appointed Mr. Aharon Klein Chief Technology Officer and a cofounder of the company to serve as its Interim Chief Executive Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Aharon Klein was appointed as Interim Chief Executive Officer at IR-Med, Inc..

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

appointed Mr. Aharon Klein Chief Technology Officer and a cofounder of the company to serve as its Interim Chief Executive Officer

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-24-008852

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.